[artículo] 
inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.9 (Septiembre) . - pp. 1524-1533

Título :	Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice
Tipo de documento:	texto impreso
Autores:	Raquel Gómez Sintes, Autor ; Analia Bortolozzi, Autor ; Francesc Artigas, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 1524-1533
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Etiquetas:	Ganglios basales, Receptores de dopamina, Estriado dorsal, Glucógeno sintasa quinasa-3 (GSK-3), Esquizofrenia
Resumen:	Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase with constitutive activity involved in cellular architecture, gene expression, cell proliferation, fate decision and apoptosis, among others. GSK-3 expression is particularly high in brain where it may be involved in neurological and psychiatric disorders such as Alzheimer׳s disease, bipolar disorder and major depression.
Link:	./index.php?lvl=notice_display&id=26926

[artículo] Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice [texto impreso] / Raquel Gómez Sintes, Autor ; Analia Bortolozzi, Autor ; Francesc Artigas, Autor . - 2021 . - pp. 1524-1533.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.9 (Septiembre) . - pp. 1524-1533

Etiquetas:	Ganglios basales, Receptores de dopamina, Estriado dorsal, Glucógeno sintasa quinasa-3 (GSK-3), Esquizofrenia
Resumen:	Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase with constitutive activity involved in cellular architecture, gene expression, cell proliferation, fate decision and apoptosis, among others. GSK-3 expression is particularly high in brain where it may be involved in neurological and psychiatric disorders such as Alzheimer׳s disease, bipolar disorder and major depression.
Link:	./index.php?lvl=notice_display&id=26926